Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Propanc Biopharma, Inc. (PPCB)

$1.37 -5.52% NASDAQ: PPCB · 15-min delayed
  • CAMBERWELL, VICTORIA, C3
  • Public · NASDAQ: PPCB
  • 2 employees
$3.1MMarket cap
-$58.9MNet income
2Employees
PPCBNASDAQ
2012IPO

About Propanc Biopharma, Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Net income
-$58.9M
Total assets
$19.6M
Market cap
$3.1M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: PPCB
$1.37 -5.52%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$1.35 $260.00

52-week range

Market cap
$3.1M
Shares outstanding
2.4M
Open
Day range
Prev close
Volume
IPO date
Jun 15, 2012

Propanc Biopharma, Inc. (PPCB) Stock Price

  • Reported a net loss of $58.9M.
  • Trading 99% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Propanc Biopharma, Inc..

Write a review
Newsroom

News about Propanc Biopharma, Inc.

News & sentiment via Polygon.io

FAQ

Propanc Biopharma, Inc.: frequently asked questions

Is Propanc Biopharma, Inc. an American company?

Propanc Biopharma, Inc. is a US-based company headquartered in Camberwell, Victoria, C3, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Propanc Biopharma, Inc. headquartered?

Propanc Biopharma, Inc. is headquartered in Camberwell, Victoria, C3, United States.

Is Propanc Biopharma, Inc. publicly traded?

Yes — Propanc Biopharma, Inc. is a publicly traded company. Its stock trades under the ticker symbol PPCB on the NASDAQ.

What does Propanc Biopharma, Inc. do?

Propanc Biopharma, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →